Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial.
Oliva EN, Platzbecker U, Garcia-Manero G, Mufti GJ, Santini V, Sekeres MA, Komrokji RS, Shetty JK, Tang D, Guo S, Liao W, Zhang G, Ha X, Ito R, Lord-Bessen J, Backstrom JT, Fenaux P.
Oliva EN, et al. Among authors: liao w.
J Clin Med. 2021 Dec 22;11(1):27. doi: 10.3390/jcm11010027.
J Clin Med. 2021.
PMID: 35011768
Free PMC article.